A Prognostic Model Based on POCUS at ICU Admission in Critically Ill Patients With Sepsis
- Disease/Condition
- Sepsis
- Drug/Device/Intervention
- ultrasound
- Study type
- Observational
- Intervention type
- device
- Primary sponsor
- Tribhuvan University Teaching Hospital, Institute Of Medicine.
- Location
- Kathmandu, Nepal
- Phase
- N/A
- Start date
- Apr 26, 2023
- End date
- Apr 30, 2024
- Enrollment
- 186 participants
28 day status alive or dead
Sepsis is responsible for one in three patient deaths. Understanding the severity of the
 disease, directing medications, prognosticating, and communicating with family members depend
 on the ability to predict outcomes in a patient presenting with sepsis in the ICU. The
 outcome of mortality reflects the caliber of ICU treatment. This is a prospective
 observational study that will include all patients diagnosed with sepsis for point-of-care
 ultrasonography within 24 hours of admission to the ICU from April 26, 2023, to March 30,
 2024, and create a model that will predict 28 day outcome in these patients.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06082154
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06082154 through Pure Global AI's free database. This phase not specified trial is sponsored by Tribhuvan University Teaching Hospital, Institute Of Medicine. and is currently Recruiting. The study focuses on Sepsis. Target enrollment is 186 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.